# Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated

> **NCT03610412** · PHASE3 · COMPLETED · sponsor: **Coordinación de Investigación en Salud, Mexico** · enrollment: 28 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** Cinnamomum Cassia
- **OTHER:** Placebo (calcined magnesia)

## Key facts

- **NCT ID:** NCT03610412
- **Lead sponsor:** Coordinación de Investigación en Salud, Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-11-24
- **Final completion:** 2021-08-18
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03610412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03610412, "Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03610412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*